Trial Profile
Phase 2 Study of Obeticholic Acid for Lipodystrophy Patients
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 18 Dec 2023
Price :
$35
*
At a glance
- Drugs Obeticholic acid (Primary)
- Indications Lipodystrophy
- Focus Pharmacodynamics
- 11 Jan 2023 Status changed from active, no longer recruiting to completed.
- 23 Jan 2022 Planned End Date changed from 1 Jan 2022 to 1 Dec 2022.
- 23 Jan 2022 Planned primary completion date changed from 1 Dec 2021 to 1 Oct 2022.